Your browser doesn't support javascript.
loading
MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF­1R-mediated AKT and ERK pathways.
Zhou, Fangzheng; Nie, Long; Feng, Dali; Guo, Siyan; Luo, Ren'na.
Affiliation
  • Zhou F; Department of Oncology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei 441399, P.R. China.
  • Nie L; Department of Oncology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei 441399, P.R. China.
  • Feng D; Department of Radiotherapy and Chemotherapy, The Second People's Hospital of Yichang, Yichang, Hubei 43000, P.R. China.
  • Guo S; Department of Oncology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei 441399, P.R. China.
  • Luo R; Department of Oncology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei 441399, P.R. China.
Oncol Rep ; 38(3): 1857-1866, 2017 Sep.
Article in En | MEDLINE | ID: mdl-28731178

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, Tumor Suppressor / Receptors, Somatomedin / Carcinoma, Non-Small-Cell Lung / MAP Kinase Signaling System / MicroRNAs / Proto-Oncogene Proteins c-akt / Lung Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, Tumor Suppressor / Receptors, Somatomedin / Carcinoma, Non-Small-Cell Lung / MAP Kinase Signaling System / MicroRNAs / Proto-Oncogene Proteins c-akt / Lung Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: Greece